Publication | Closed Access

Antibiotic anisomycin selectively targets leukemia cell lines and patient samples through suppressing Wnt/β-catenin signaling

Leukemia Cell LinesMedicineAntibiotic AnisomycinPharmacotherapyWnt/β-catenin SignalingAntimicrobial ChemotherapyAnti-cancer AgentPharmacologyCell BiologyCancer ResearchTumor Biology